B4RNA develops a liquid biopsy diagnostic for early cancer detection using a proprietary RNA repair and sequencing method.
B4-RNA has raised $750K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2024.
B4-RNA is headquartered in Montevideo, Uruguay.
B4RNA develops a liquid biopsy diagnostic for early cancer detection using a proprietary RNA repair and sequencing method.
B4-RNA is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"B4-RNA — Funding & Investors." VCBacked, March 5, 2024, https://www.vcbacked.co/company/b4-rna. Accessed August 15, 2026.
VCBacked. (2024). B4-RNA — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/b4-rna
{{cite web |title=B4-RNA — Funding & Investors |url=https://www.vcbacked.co/company/b4-rna |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated